
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Genentech's sprawling campus overlooking San Francisco Bay seems serene on the surface, but internally, the company resonates with energy.
over 25 years ago
Internet DTC - Minding Your P's & Q'sover 25 years ago
Regulation: Two-Track Planover 25 years ago
Policy: Tectonic Shiftover 25 years ago
Liberated?over 25 years ago
A Matter of Tasteover 25 years ago
Partnerships: Bargaining Biotechsover 25 years ago
Pediatric Mandateover 25 years ago
Regulation: OK After All





